Hbk Investments L P Alnylam Pharmaceuticals, Inc. Transaction History

Hbk Investments L P

  • $5.14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $2.77 Million - $4.63 Million
19,975 New
19,975 $4 Million
Q3 2018

Nov 14, 2018
SELL
$87.52 - $122.67 $32,294 - $45,265
-369 Reduced 2.73%
13,131 $1.15 Million
Q2 2018

Aug 14, 2018
BUY
$88.31 - $107.8 $1.19 Million - $1.46 Million
13,500 New
13,500 $1.33 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.6B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email